These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7515559)

  • 1. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.
    van Agthoven T; Timmermans M; Foekens JA; Dorssers LC; Henzen-Logmans SC
    Am J Pathol; 1994 Jun; 144(6):1238-46. PubMed ID: 7515559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soy consumption and histopathologic markers in breast tissue using tissue microarrays.
    Maskarinec G; Erber E; Verheus M; Hernandez BY; Killeen J; Cashin S; Cline JM
    Nutr Cancer; 2009; 61(5):708-16. PubMed ID: 19838945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen And Progesterone Receptors' Expression Pattern In Fibro-Adenoma Of The Female Breast.
    Naeem S; Naz S; Amanullah K; Javed H; Khan O; Afridi EAK; Ahmed S
    J Ayub Med Coll Abbottabad; 2023; 35(3):400-404. PubMed ID: 38404080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical phenotyping of breast cancer using MEMS: a method to demarcate benign and cancerous breast tissues.
    Pandya HJ; Chen W; Goodell LA; Foran DJ; Desai JP
    Lab Chip; 2014 Dec; 14(23):4523-32. PubMed ID: 25267099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between low estrogen receptor positive breast cancer and staining performance.
    Caruana D; Wei W; Martinez-Morilla S; Rimm DL; Reisenbichler ES
    NPJ Breast Cancer; 2020; 6():5. PubMed ID: 32047851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.
    Lung DK; Reese RM; Alarid ET
    Horm Cancer; 2020 Aug; 11(3-4):129-147. PubMed ID: 32592004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions.
    Wang Y; Wang Y; Wei L; Hong S; Zhao M; Zhang X; Zheng W
    J Ovarian Res; 2017 Mar; 10(1):12. PubMed ID: 28270171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.
    Verbeke S; Richard E; Monceau E; Schmidt X; Rousseau B; Velasco V; Bernard D; Bonnefoi H; MacGrogan G; Iggo RD
    Breast Cancer Res; 2014 Dec; 16(6):504. PubMed ID: 25527189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of traditional and new biomarkers in breast carcinogenesis.
    Macis D; Cazzaniga M; De Censi A; Bonanni B
    Ecancermedicalscience; 2009; 3():157. PubMed ID: 22276018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to depleted uranium does not alter the co-expression of HER-2/neu and p53 in breast cancer patients.
    Al-Mumen MM; Al-Janabi AA; Jumaa AS; Al-Toriahi KM; Yasseen AA
    BMC Res Notes; 2011 Mar; 4():87. PubMed ID: 21443808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive changes result in activation of alternate signaling pathways and acquisition of resistance to aromatase inhibitors.
    Brodie A; Sabnis G
    Clin Cancer Res; 2011 Jul; 17(13):4208-13. PubMed ID: 21415222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers.
    Brinkman JA; El-Ashry D
    J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):67-78. PubMed ID: 19263197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
    Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
    Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours.
    Clemons MJ; Bibby MC; El Teraifi H; Forster G; Kelly J; Banerjee S; Cadman B; Ryder WD; Howell A; Margison GP
    Br J Cancer; 2002 Jun; 86(11):1797-802. PubMed ID: 12087469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of breast cancer: implications for postmenopausal women.
    Fabian CJ; Kimler BF
    Drugs Aging; 2002; 19(1):43-78. PubMed ID: 11929326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen resistance in breast cancer: elucidating mechanisms.
    Dorssers LC; Van der Flier S; Brinkman A; van Agthoven T; Veldscholte J; Berns EM; Klijn JG; Beex LV; Foekens JA
    Drugs; 2001; 61(12):1721-33. PubMed ID: 11693462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas.
    La Rosa S; Sessa F; Colombo L; Tibiletti MG; Furlan D; Capella C
    J Clin Pathol; 2001 Jan; 54(1):37-41. PubMed ID: 11271786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.
    Hansen RK; Bissell MJ
    Endocr Relat Cancer; 2000 Jun; 7(2):95-113. PubMed ID: 10903527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland.
    De Bortoli M; Dati C
    J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):175-85. PubMed ID: 10882303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor variants.
    Hopp TA; Fuqua SA
    J Mammary Gland Biol Neoplasia; 1998 Jan; 3(1):73-83. PubMed ID: 10819506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.